Table 1. Study set characteristics and conclusions.

Characteristic	Sponsorship industry (n=44)	Sponsorship nonprofit (n=106)	P-value
Analysis type
Cost minimisation	17	16
Cost effectiveness	19	76	0.004
Cost utility	6	12
Cost–benefit	2	2
Technology assessed
Pharmaceuticals	36	25
Surgery	3	15
Screening	1	42
Diagnostics	3	18	<0.0001
Devices	1	2
Supportive care	0	3
Pharmacokinetic monitoring	0	1
Publication status
Non-peer reviewed	8	8	0.08
Peer reviewed	36	98
Sensitivity tested
Yes	26	52	0.29
No	18	54
Qualitative conclusions about costs
Positive	27	35
Negative	7	16	0.002
Neutral	10	55